Motion-preserving arthroplasty for end-stage ankle arthritis via anterior approach | advanced
Surgical Imaging
Location: The neurovascular bundle lies immediately deep to the extensor retinaculum in the interval between tibialis anterior and extensor hallucis longus.
Risk: Aggressive medial retraction or blind dissection can transect the deep peroneal nerve or anterior tibial artery. Identify the bundle under direct vision and protect it with a vessel loop before capsulotomy.
Location: The medial malleolus is at risk during tibial resection if the saw blade exits medially; the lateral malleolus is vulnerable during fibular gutter preparation.
Risk: Intraoperative malleolar fracture occurs in 5-10 percent of cases and is associated with poor outcomes. Use narrow oscillating saw blades, protect the malleoli with retractors, and consider prophylactic K-wire stabilisation in osteopenic bone.
Location: The talar component relies on subchondral bone stock — patients with prior trauma, AVN, or large cysts have reduced support.
Risk: Subsidence greater than 3 mm leads to component migration, edge loading, and early failure. Preoperative CT assesses talar bone quality; bone graft or custom implants may be required in deficient cases.
Location: Neutral mechanical axis and 3-5 degrees posterior tibial slope are required for mobile-bearing implants.
Risk: Varus greater than 5 degrees or valgus greater than 10 degrees causes asymmetric polyethylene wear and instability. Use extramedullary or computer-assisted alignment guides and verify with intraoperative fluoroscopy before final implantation.
Location: The anterior ankle incision is under tension with ankle motion and is vulnerable in patients with prior surgery, diabetes, or peripheral vascular disease.
Risk: Superficial wound breakdown occurs in 5-15 percent; deep infection follows in up to 3 percent. Use full-thickness flaps, avoid undermining, close in layers without tension, and consider plastic surgery consultation for high-risk patients.
Location: Stress risers at the tibial keel or talar pegs; polyethylene wear particles cause osteolysis around the components.
Risk: Periprosthetic fracture risk is 2-5 percent at 5 years. Osteolysis presents with cystic lucencies on radiographs. Serial surveillance radiographs every 1-2 years detect early bone loss before catastrophic failure.
A.L.I.G.N.ALIGN — Preoperative Planning and Alignment Goals
A.N.T.E.R.I.O.R.ANTERIOR — Approach and Intraoperative Safeguards
F.A.I.L.FAIL — Common Modes of Failure and Prevention
Indications for Total Ankle Replacement
Primary Indications
- End-stage primary or post-traumatic tibiotalar osteoarthritis with preserved motion and low-to-moderate physical demand
- Adjacent-joint arthritis (subtalar or talonavicular) where arthrodesis would accelerate degeneration of those joints
- Patients who prioritise motion preservation over fusion for functional activities such as stair climbing or uneven ground walking
Contraindications
Absolute:
- Active or recent deep infection
- Avascular necrosis of the talus with collapse
- Severe fixed coronal deformity greater than 15-20 degrees not correctable by osteotomy
- Peripheral neuropathy (Charcot neuroarthropathy)
- Insufficient bone stock for component support
Relative:
- High physical demand (manual labour, high-impact sports)
- Obesity (BMI greater than 35)
- Poor soft-tissue envelope or prior anterior incisions with compromised vascularity
- Young age (less than 50 years) with long life expectancy
Evidence Comparing TAR versus Arthrodesis
Functional Outcomes
- Modern three-component mobile-bearing implants achieve 20-30 degrees of sagittal motion and improve AOFAS scores by 30-40 points at 5 years
- Gait analysis demonstrates more physiologic ankle kinematics and reduced compensatory knee and hip motion compared with arthrodesis
- Patient-reported outcomes favour TAR for activities requiring ankle dorsiflexion; fusion patients report higher rates of adjacent-joint pain at 10 years
Survivorship and Revision
- Registry data (NJR, AJRR, AOANJRR) show 5-year survivorship of 85-92 percent and 10-year survivorship of 70-85 percent for contemporary implants
- Revision rate at 10 years is approximately 15-25 percent — most commonly for aseptic loosening, subsidence, or infection
- Arthrodesis has lower re-operation rate for the index joint but higher rates of symptomatic adjacent-joint arthritis requiring later fusion
Complications
- Wound complications and infection are higher after TAR (5-15 percent wound issues, 1-3 percent deep infection) than after arthrodesis
- Non-union after arthrodesis occurs in 5-10 percent of cases and may require revision surgery
- Both procedures carry risk of deep-vein thrombosis, but TAR patients mobilise earlier
TAR versus Ankle Arthrodesis — Decision Framework
\1
Better implant survival with modern ankle prosthetic designs: 1,226 total ankle prostheses followed for up to 20 years in the Swedish Ankle Registry
The Agility Total Ankle Arthroplasty: A Concise Follow-up at a Minimum of 20 Years
Early Clinical Outcomes and Complications of Transfibular Total Ankle Arthroplasty: The Australian Experience
Survivorship of 4,748 Contemporary Total Ankle Replacements from the French Discharge Records Database
Clinical Decision Scenarios
Practise clinical reasoning and management decisions out loud
“A 62-year-old woman with post-traumatic ankle arthritis presents with severe pain and stiffness. Standing radiographs show end-stage tibiotalar osteoarthritis with neutral coronal alignment, 5 degrees posterior tibial slope, and preserved talar bone stock. She is a retired office worker who walks daily for exercise. Discuss your surgical recommendation and the key technical steps for total ankle replacement.”
“You are planning total ankle replacement on a 58-year-old man with primary ankle osteoarthritis. Standing radiographs demonstrate 12 degrees of varus deformity with medial gutter narrowing and deltoid ligament contracture. How do you decide between corrective osteotomy, TAR, and arthrodesis?”
“A 65-year-old woman is 18 months after total ankle replacement with a mobile-bearing implant. She presents with new-onset activity-related pain and swelling. Standing radiographs show a 4 mm lucent line around the tibial component and cystic changes in the talus. What is your diagnostic work-up and management plan?”